CompletedPHASE2, PHASE3NCT02804373

Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome

Studying Prader-Willi syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Toulouse
Principal Investigator
Maithé TAUBER, MD
University Hospital, Toulouse
Intervention
Oxytocin (OXT) continuous(drug)
Enrollment
50 enrolled
Eligibility
18-50 years · All sexes
Timeline
2014 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02804373 on ClinicalTrials.gov

Other trials for Prader-Willi syndrome

Additional recruiting or active studies for the same condition.

See all trials for Prader-Willi syndrome →

← Back to all trials